Summit Avenue Medical is categorized under Internal Medicine Doctors in Hackensack, NJ and active since 1985.
Summit Avenue Medical was established in 1985, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ann Glodfarb, Office Manager at the company’s single location by writing to 5 Summit Avenue # 101, Hackensack, New Jersey NJ 07601 or by phoning (201) 646-0001. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Summit Avenue Medical |
Contact Person: | Ann Glodfarb, Office Manager |
Address: | 5 Summit Avenue # 101, Hackensack, New Jersey 07601 |
Phone Number: | (201) 646-0001 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Summit Avenue Medical was started in 1985 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Ann Glodfarb, Office Manager for inquiries that concern Summit Avenue Medical by calling the company number (201) 646-0001, as your correspondence is most welcome. Additionally, the physical location of the single location of Summit Avenue Medical can be found at the coordinates 40.8845,-74.0596 as well as the street address 5 Summit Avenue # 101 in Hackensack, New Jersey 07601.
For its online presence, you may visit Summit Avenue Medical’s website at and engage with its social media outlets through on Twitter and on Facebook.